TMDX trade ideas
12/5/24 - $tmdx - I'm back... buying sub $7012/5/24 :: VROCKSTAR :: NASDAQ:TMDX
I'm back... buying sub $70
- check out last post when i opportunistically bot this thing
- some Q's on last call ppl pointing out about "seasonality" being a bit sus. interesting. yeah CEO did act a bit defensive and i don't have context or know the chad
- but growth remains solid, PE a bit high but for that growth (if just a blip) is a good oppty. they're nicely positioned here.
- i like the idea of buying shares (which i've now done/ not options) and any retrace back toward low 70s i'm selling the dec 19 2025 calls probably at the 65 or 70 strike to "capture" a 30% yield bc i think in worst case downside here is to the 50s and that premium more than accounts for that lower basis
- what do u think? ride r die crew
V
Catching the TransMedics Group - $TMDX Falling KnifeTransMedics Group - NASDAQ:TMDX
For current and new shareholders here is your buying range for this company.
This could be the bounce that sends us back towards ATH's. But, if we were to fall lower I think it would be capped out around the 200MA.
DCA Buying Range: $55-$90
AVP GAP Fill to $134
NFA
TMDXNASDAQ:TMDX is likely heading lower to complete the impulse in the wave C of a running flat. I will start buying within the range $60-70.
There are two typical dimensions for the wave C of a flat - wC=wA or times 1,618.
Zooming in the daily/ 4h frame - there is a clear impulsive move down, that is lacking the final wave 5, printing a lower low.
Buying the lower low is more or less safe, and here is why...
If the assumption is not valid - and this is not the wave C of a flat, this impulse is then the wave A of a larger structure. Even so, we will get a deep pullback by 50-62% against this bearish move.
In any case, the most safe entry would be after the bullish 1-2 fractal is printed on H4/ D1. It may take a look of an inverted Head and shoulders pattern, together with the w4 of C of the last move down.
TRADE SAFE
Call the TransMedicsInteresting stock, the high growth that propelled it to a 600% plus gain is slowing down. Management claim it’s due to seasonal pressure, not sure if I can believe there’s a season for organ donors but now I know there is!
We’ve since had a 50% haircut in the last month. It’s going to be a turbulent 2-3 months for this stock as they try to maintain growth whilst make use of their new aviation fleet. I’m not a fan of any company trying to use their own planes to deliver products or services, but organ donor is a unique business.
From a technical standpoint we are sat at the weekly support and golden Fibonacci support ratio, along with a speed fan. If this is all lost we could tumble to $73 very quickly.
It’s worth a trade here if you can keep a tight stop loss, if that fails, consider going long in the low 70s. Not financial advice of course, you do you.
10/30/24 - $tmdx - Buying 11/15 C's sub $8510/30/24 :: VROCKSTAR :: NASDAQ:TMDX
Buying 11/15 C's sub $85
- this price action looks VERY similar to all the stonks that are getting rekt beyond the 25% threshold. it's incredible how similarly the mkt treats these things. by mkt i mean the AGI that controls us all at this pt and nobody wants to talk about it beyond my friends that don the tin foil ;)
- look at something like NASDAQ:ASML in the first two days, that's the "best" comp for something like this atm
- second day is de risking by those who were diligently swiss cheese. then. thu and fri it reverses for the sake of market makers. right now we are taking out longs. then we get the shorts rekt.
- so i'm not suggesting this is a LT buy just yet at these levels (i do think we'd probably see 70s in the coming months, so similar to say $CROX... if you like to buy/ hold stuff for long long time periods, you'll probably be fine at this level...
i just like to hold other things). that said, i think it's an interesting oppty to use leverage to play the retrace.
it's about a 1% position i have in 11/15 80C's, which is a bit aggressive and taking advantage of bumper crop in OTC:GDLC then OTC:BITW wins lately.
V
$TMDX Strong stock move from this organ transport companyNASDAQ:TMDX This is a green ants stock. So one of the top stocks on my list.
No pullback and looks like going up farther more after earnings gap up. But since it is very extended I will keep stops very tight. Prefer a decent pullback and then bounce.
$TMDX Undercut and Rally NASDAQ:TMDX had solid earnings yesterday but good to look back and analyse how the stock behaves prior with an undercut and rally #UNR.
You will noticed that the 21EMA crosses down the 50EMA and subsequently crosses up.
From there, the 8EMA intersect together with the classic "PINCH" to rally. Though the earnings was a catalyst. Institutions would have some guesstimates on the performance of this company in transporting live organs.
Some unique proposition which is key in selecting stocks too and fundamentals as well behind the surge. Could it be a POWERTREND? Let's observe.
TransMedics Group, Inc. (TMDX:NASDAQ): Strong Q2 PerformanceTransMedics Group, Inc.: Strong Q2 Performance and Ambitious Expansion Plans
Exceptional Q2 Performance: TransMedics Group's Remarkable Growth: Achieving Record Revenues and Unprecedented Second-Quarter Turnover
TransMedics Group, Inc. has demonstrated remarkable growth in its Q2 results, showcasing a significant 156% year-on-year increase in revenues. This achievement marks the highest second-quarter turnover in the company's history, underscoring its ability to capitalize on market opportunities effectively.
Ambitious Expansion Goals: Achieving Full U.S. Continent Availability: Aiming for Comprehensive Reach by Mid-Next Year
With a forward-focused strategy, TransMedics Group aims to establish 100% availability over the entire U.S. continent by the middle of next year. This ambitious goal reflects the company's commitment to enhancing its service coverage and ensuring that its innovative solutions reach healthcare facilities across the nation.
Strengthening Air Logistics: Acquisition of Additional Aircraft: Strategic Move to Enhance Air Logistics Operations
TransMedics Group is set to reinforce its air logistics operations by acquiring 10 to 15 aircraft. This strategic initiative aligns with the company's dedication to optimizing its capabilities and resources, thereby facilitating efficient organ transportation and bolstering its overall operational excellence.
Conclusion:
TransMedics Group, Inc. has not only posted exceptional Q2 results with an impressive YoY increase in revenues but also showcased its commitment to expansion and improvement. The company's aspiration of achieving 100% availability across the U.S. continent and its strategic plan to acquire additional aircraft for its air logistics operations underscore its determination to excel. With these positive developments in mind, it is recommended to reiterate a "buy" position on TransMedics Group, Inc., while revising the price objective to $150 per share to reflect its promising growth trajectory.
This content is provided for general information purposes only and is not to be taken as investment advice nor as a recommendation for any security, investment strategy or investment account.